市場調查報告書
商品編碼
1197603
顯微外科器械市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)Microsurgical Instruments Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
在預測期內 (2023-2028),顯微外科器械市場預計將以 5.1% 的複合年增長率增長。
COVID-19 大流行對世界各地的所有行業產生了重大影響,尤其是醫療保健系統,它不僅影響了感染 COVID-19 的患者,還影響了其他患者,取消和重新安排手術以管理和確保安全急救資源以及許多醫院的外科醫生短缺也影響了顯微外科器械市場。 例如,根據 2021 年 12 月於 2020 年 3 月至 2020 年 4 月在美國發表的題為“美國外科手術趨勢和醫療保健系統對政策限制選擇性外科手術在 COVID-19 大流行期間的反應”的研究,在暫停的第一個時期,手術治療量下降到基線率的一半左右,在 2020 年 3 月建議暫停擇期手術後,總手術量下降了 48%。 數據顯示,由於 COVID-19,手術量顯著下降,因此 COVID-19 預計將對顯微外科器械市場產生重大影響。
隨著全球顯微外科手術數量的增加,顯微外科手術相對於傳統外科手術的巨大優勢是主要因素之一。 例如,根據一項於 2021 年 6 月發表的題為“使用 Alloderm 治療美學區局部牙齦退縮的微創顯微外科手術與傳統手術的隨機對照試驗”的研究,在放大鏡下對根管治療進行了顯微鏡檢查。發現手術優於傳統顯微手術,改善牙齦厚度和患者滿意度的評估,以及顯微手術部位新血管的更快癒合。預計未來顯微手術設備的市場規模將繼續擴大.
同樣,根據 2022 年 5 月發表的“使用高清 3D 外窺鏡進行頸椎顯微手術:優點和缺點”的研究報告,高清三維 (3D) 內窺鏡 (EX) 具有獨特的優點舒適,似乎是傳統頸椎前路椎間盤切除融合術 (ACDF) 的可靠替代方案。據報導,它還具有作為外科團隊有用教育工具的優點。 因此,由於顯微外科手術相對於傳統手術具有許多優勢,顯微外科手術的採用預計會增加,這有望增加對顯微外科器械的需求,因此在預測期內。市場預計將在
此外,由於慢性病負擔不斷增加,全球手術數量不斷增加,預計將在預測期內促進顯微外科器械市場的增長。 例如,2020 年 9 月發表的一項題為“通過列舉全民健康覆蓋下城市社區的外科手術來估計印度國家外科手術需求”的研究發現,全球約 11% 的疾病負擔是手術或麻醉劑治療,或兩者兼而有之,估計需要進行 3,646 次手術才能滿足印度人口的手術需求,而全球估計每 100,000 人需要進行 5,000 次手術。據說全年都需要手術。 隨著全球外科手術需求的增加,顯微手術器械的需求也在增加,市場有望增長。
此外,需要手術治療的慢性病負擔預計會增加,這有望對研究市場產生積極影響。 例如,根據美國疾病控制與預防中心 2022 年 7 月的更新,冠心病是美國最常見的心髒病類型,影響了大約 2010 萬 20 歲以上的成年人。 因此,由於上述因素,預計顯微外科器械市場將在預測期內增長。 然而,高昂的手術費用預計將在預測期內抑制顯微手術器械市場的增長。
由於美容行業的興起以及人們對自己外表的自我意識不斷增強,對重建和整形手術的需求不斷增加等因素,預計整形和重建顯微外科手術將佔該細分市場的最大份額.增加。 例如,根據國際美容整形外科學會(ISAPS)2020年的報告,全球約有1010萬例整容手術,其中美國是手術數量最多的國家。 此外,根據美國整形外科學會發布的 2020 年統計數據,2020 年全球共進行了 6,878,486 次重建手術,而 2019 年為 6,652,591 次。 因此,預計全球範圍內進行的大量整形和重建手術將推動這一領域的增長。
此外,市場參與者在顯微外科器械方面的技術進步以及產品發布、併購和合作等其他業務擴張計劃預計將在預測期內推動整形和重建顯微外科領域的增長。預計進一步增加。 例如,2020 年 10 月,MMI SpA 在歐洲推出了用於開放式顯微外科手術的 Symani 手術系統,據該公司稱,Symani 手術系統具有運動縮放和減少震顫的優點,並且手腕器械最少。我有它。 因此,由於上述因素,預計在預測期內,整形和重建顯微外科領域將佔有很大的市場份額。
在北美地區,由於骨科疾病和神經系統疾病等慢性病患病率上升,老年人口不斷增加,以及該地區對整形和重建手術的需求增加等因素,對顯微外科手術的需求預計在預測期內將繼續增長,預計將佔據設備市場的很大份額。 例如,根據加拿大健康信息研究所 2021 年 6 月的一份報告,從 2019 年到 2020 年,加拿大進行了 63,496 例髖關節置換術和 75,073 例膝關節置換術。髖關節置換術平均增加了約 5%。
此外,在國際美容整形外科學會 (ISAPS) 於 2021 年 12 月發布的 2020 年報告中,美國和墨西哥位列整容手術數量最多的前 10 個國家之列。預計看到北美地區對顯微外科器械的高需求。
在北美地區,美國有望成為最大的市場。 這是由於該國針對慢性病和美容目的的手術數量很多,慢性病負擔不斷增加等因素。 例如,根據美國整形外科醫師協會(ASPS)2020年的報告,2020年美國約有1560萬人接受整容手術,其中230萬人接受整容手術,1320萬人接受微創美容。如同一材料所示,由於對整容手術的需求增加,在日本進行的手術數量正在增加。
此外,為佔領該地區更大的市場而開展的產品發布、併購和合作等企業活動預計將對市場產生重大影響。 例如,2022 年 2 月,瑞典醫療器械製造商 Stille AB 與 Synovis Micro Companies Alliance, Inc 簽訂獨家經銷協議,成為美國手術器械的獨家經銷商。 因此,由於上述因素,預計北美地區在預測期內將在顯微外科器械市場佔據重要市場份額。
顯微外科器械市場競爭適中,由幾家主要參與者組成。 從市場份額的角度來看,一些主要參與者目前主導著市場。 一些知名企業正在積極收購其他公司並推出新產品,以鞏固其在全球的市場地位。 一些主要參與者是 Olympus Corporation、KLS Martin Group、World Surgical Corporation、ZEISS International 和 Karl Kaps GmbH & Co 等公司。
The microsurgical instruments market is expected to register a CAGR of 5.1% during the forecast period (2023 - 2028).
The COVID-19 pandemic had a significant influence on all the industries throughout the world, especially on the healthcare systems which affected not only the patients infected with COVID-19 but others as well, which resulted in the cancellation or rescheduling of surgeries to manage and reserve the resources for COVID-19 or emergency ones and also, many hospitals have a shortage of surgeons to perform surgeries which also had its effect on the microsurgical instrument market. For instance, according to the research study published in December 2021, titled "Trends in US Surgical Procedures and Health Care System Response to Policies Curtailing Elective Surgical Operations During the COVID-19 Pandemic", in the United States, the surgical treatment volume fell to around half of baseline rates during the initial shutdown period in March through April 2020 and following the recommendation to stop performing elective surgery in March 2020, the volume of all surgical procedures dropped by 48%. This data shows a significant decline in surgical procedures due to COVID-19 and thus, COVID-19 is expected to have a profound impact on the microsurgical instruments market.
The significant advantage of microsurgery over conventional surgical procedures is one of the major factors because of which the number of microsurgical procedures is increasing around the world. For instance, according to a research study published in June 2021, titled "A Randomized Controlled Trial on a Minimally Invasive Microsurgical Versus Conventional Procedure for the Management of Localized Gingival Recession in Esthetic Zone Using Alloderm", under magnification, the microsurgical method for root coverage was found to be superior to the traditional microsurgical method and in addition to enhanced gingival thickness and patient satisfaction ratings, neovascularization at the microsurgical sites healed more quickly.
Similarly, according to a research study published in May 2022, titled "Cervical Spine Microsurgery with the High-Definition 3D Exoscope: Advantages and Disadvantages", it was reported that the high-definition 3-dimensional (3D) exoscope (EX) offers a unique benefit of good comfort and appears to be a secure substitute for conventional anterior cervical discectomy and fusion (ACDF) and it also benefits the surgical team as a useful educational tool. Hence, owing to the many advantages of microsurgical procedures over conventional procedures, the adoption of microsurgical procedures is expected to increase which is expected to increase the demand for microsurgical instruments and, thus, the market is expected to grow over the forecast period.
Furthermore, the increasing number of surgeries around the world owing to the growing burden of chronic diseases is expected to augment the growth of the microsurgical instruments market during the forecast period. For instance, as per the research study published in September 2020, titled "Estimation of the National Surgical Needs in India by Enumerating the Surgical Procedures in an Urban Community Under Universal Health Coverage", about 11% of the global burden of disease requires surgical or anesthesia care or both, and an estimated 3,646 surgeries would be required annually to meet the surgical needs of the Indian population as compared to the global estimate which is 5,000 surgeries per 100,000 people. Thus, with the rising demand for surgical procedures around the world, the demand for microsurgical instruments is expected to which is anticipated to boost the market growth.
In addition, the increasing burden of chronic diseases that require surgical treatment is expected to increase which is expected to have a positive impact on the studied market. for instance, according to the July 2022 update of the Centers for Disease Control and Prevention coronary heart disease is the most common type of heart disease in the United States that affecting about 20.1 million adults aged 20 and older. Hence, owing to the above-mentioned factors, the microsurgical instruments market is expected to grow over the forecast period. However, the high cost associated with the surgery is expected to restrain the growth of the microsurgery instruments market during the forecast period.
The plastic and reconstructive microsurgery segment is expected to hold the largest share in this market segment, owing to the factors such as the growing demand for reconstructive and plastic surgery due to the rise in the aesthetics industry and greater self-awareness among people about their looks. For instance, according to the 2020 report of the International Society for Aesthetic Plastic Surgery (ISAPS), about 10.1 million cosmetic surgical procedures were performed around the world and the United States was the largest country by volume of surgeries. Further, according to the 2020 statistics published by the American Society of Plastic Surgeons, a total of 6,878,486 reconstructive procedures were performed in 2020, globally, as compared to 6,652,591 procedures in 2019. Hence, the high number of plastic and reconstructive surgeries being performed around the world is expected to boost the segment's growth.
Additionally, technological advancement in the microsurgery instruments by the players in the market along with other business expansion initiatives such as product launches, mergers, and acquisitions, and collaboration, among others are further expected to augment growth in the plastic and reconstructive microsurgery segment over the forecast period. For instance, in October 2020, MMI SpA launched Symani Surgical System in Europe for open microsurgical procedures, and as per the company, the Symani Surgical System combines the advantages of motion scaling and tremor reduction with the smallest wristed instrumentation. Therefore, due to the above-mentioned factors, the plastic and reconstructive microsurgery segment is expected to have a significant market share over the forecast period.
North America region is expected to hold a significant share in the microsurgical instruments market over the forecast period due to factors such as the rising prevalence of chronic disorders such as orthopedic disorders, neurological disorders, rising geriatric population, and growing demand for plastic and reconstructive surgeries in the region. For instance, as per the June 2021 report of the Canadian Institute of Health Information, 63,496 hip replacements and 75,073 knee replacements were performed from 2019 to 2020 in Canada, and there was an average increase of about 5% in recent years in the knee and hip replacement procedures in the country.
Also, as per the 2020 report of the International Society for Aesthetic Plastic Surgery (ISAPS) published in December 2021, the United States and Mexico were one of the top ten destinations with the highest number of cosmetic surgeries and hence, the demand for microsurgical instruments is expected to be high in the North America region over the forecast period.
In the North American region, the United States is expected to be the largest market owing to the factors such as a high number of surgeries being performed in the country for chronic diseases as well as cosmetic purposes, the growing burden of chronic diseases, and other factors. For instance, according to the 2020 report of the American Society of Plastic Surgeons (ASPS), about 15.6 million people have undergone cosmetic procedures in the United States, among which 2.3 million were cosmetic surgical procedures and 13.2 million were cosmetic minimally invasive procedures in 2020 and as per the same source, the number of procedures is increasing in the country owing to the increasing demand of the cosmetic surgical procedures.
Furthermore, the company activities such as product launches, mergers and acquisitions, and collaboration to acquire a greater market in the region are further expected to have a significant impact on the market. For instance, in February 2022, Swedish medical device company Stille AB signed an exclusive distribution agreement with Synovis Micro Companies Alliance, Inc, as its exclusive distributor of surgical instruments in the United States. Therefore, due to the above-mentioned factors, the North American region is expected to hold a significant market share in the microsurgery instruments market during the forecast period.
The Microsurgical Instruments market is moderately competitive and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and new product launches with other companies to consolidate their market positions across the globe. some of the key players are Olympus Corporation, KLS Martin Group, Global Surgical Corporation, ZEISS International, and Karl Kaps GmbH & Co. among others.